VGXI announced that on April 10th, 2017 the corporation won the award for Best Production / Process Development at the 10th Annual ViE Awards Ceremony held at the 2017 World Vaccine Congress in Washington, D.C.
VGXI Wins 2017 Vaccine Industry Excellence (ViE) Award for Best Contract Manufacturing Organization
IVI, GeneOne Life Science join forces to develop MERS-CoV vaccine
IVI and GeneOne Life Science to collaborate in clinical development of GeneOne’s DNA-based MERS-CoV vaccine. The collaboration will accelerate vaccine development and ensure access for public health readiness in case of future outbreaks in Korea and worldwide. Signing ceremony for MERs-CoV vaccine development collaboration. The International Vaccine Institute (IVI) and GeneOne Life Science Inc. have… Read More »
VGXI Hosts Biotech Roundtable Discussion with U.S. Congressman Pete Olson
On November 18, 2016 VGXI hosted a roundtable discussion with US Congressman Pete Olson and key biotech industry leaders. From left: U.S. Congressman Pete Olson; Ann Tanabe, CEO of BioHouston; Young Park, CEO of GeneOne Life Science; Jim Greenwood, President of BIO; Dorothy Peterson, VP of Operations at VGXI; and Tom Kowalski, President and CEO… Read More »
GeneOne Life Science Doses First Subjects in Zika Vaccine Trial
SEOUL, KOREA (PRWEB) JULY 26, 2016 GeneOne Life Science, Inc. (“GeneOne” KOSPI: 011000) today announced the dosing of the first subjects in its multi-center Phase I trial to evaluate the Zika DNA vaccine (GLS-5700). Refer to ClinicalTrials.Gov, study number NCT02809443. GeneOne has received approval from both the US FDA and Health Canada’s Health Products and… Read More »
VGXI Celebrates Facility Expansion Grand Opening
U.S. Congressman Kevin Brady visits VGXI to celebrate the grand opening for their new small scale cGMP manufacturing facility, located in The Woodlands, TX. VGXI Ribbon Cutting, from left: J.J. Hollie, President and CEO of The Woodlands Chamber of Commerce; U.S. Congressman Kevin Brady; Young Park, CEO of GeneOne Life Science; Dorothy Peterson, VP of… Read More »
View our poster presented at the ASGTC 2016 Annual Meeting
Did you miss us at ASGCT? Download our poster at the link below: Challenges of Production of Nanoplasmid™ with Large Gene insert using the HyperGRO™ Fermentation Process Presented on Friday, May 6, 2016 from 6:00 pm – 8:00 pm Session Information: Vector and Cell Engineering/Manufacturing II Location: Exhibit Hall C & B South Abstract #712… Read More »
VIDEO: VGXI Celebrates Opening of ABICS
On June 18th, 2015 VGXI celebrated the opening of the Advanced Biopharmaceuticals International Center of Support (ABICS) at their facility in The Woodlands, TX. View the video below. In response to the recent MERS outbreak, the Texas-based clinical manufacturing organization, VGXI has rapidly mobilized in collaboration with the Korean company GeneOne Life sciences to expedite… Read More »
VIDEO: Congressman Visits VGXI Facility to Celebrate DARPA Award and Ebola Vaccine Manufacturing
VGXI supports expedited development and scale-up of multiple vaccine candidates to treat Ebola through a DARPA funded collaboration. Click below to view the video. US Congressman Kevin Brady visited the VGXI manufacturing facility in The Woodlands, TX on May 4th, 2015 to tour the production plant and provide a statement on the impact of this… Read More »
Positive Data Announced in Phase IIb Clinical Trial of Cystic Fibrosis Gene Therapy Manufactured by VGXI
Positive clinical data has been published for a cystic fibrosis gene therapy clinical trial supported by the cGMP plasmid DNA manufacturing services of the Texas-based CMO, VGXI. Recently, the United Kingdom Cystic Fibrosis Gene Therapy Consortium (UKCFGTC) published the first clinical data from a Phase IIb, multi-dose clinical trial for cystic fibrosis. In this trial,… Read More »
VIDEO: Get an inside look at VGXI in a Discovery Channel Exclusive Segment
Click on the link below to view the Innovations TV show featuring VGXI. This show aired on the Discovery Channel on June 26, 2015.
VGXI Celebrates Opening of the Advanced Biopharmaceuticals International Center of Support
On June 18th, 2015 VGXI celebrated the opening of the Advanced Biopharmaceuticals International Center of Support (ABICS) at their facility in The Woodlands, TX. In response to the recent MERS outbreak, the Texas-based clinical manufacturing organization, VGXI has rapidly mobilized in collaboration with the Korean company GeneOne Life sciences to expedite production and Phase I clinical… Read More »
Congressman Kevin Brady visited VGXI on May 4, 2015
VGXI to support expedited development and scale-up of multiple vaccine candidates to treat Ebola through a DARPA funded collaboration. US Congressman Kevin Brady visited the VGXI manufacturing facility in The Woodlands, TX on May 4th, 2015 to tour the production plant and provide a statement on the impact of this work and the DNA-based therapeutics… Read More »